Evidence map›Paper›PMID 27771962›Full record

Observational studyAIDS research and human retroviruses2016

Humoral Antibody Responses to HIV Viral Proteins and to CD4 Among HIV Controllers, Rapid and Typical Progressors in an HIV-Positive Patient Cohort.

Elizabeth Fink, Katherine Fuller, Brian Agan, Edward A Berger, Andrew Saphire, Gerald V Quinnan, John H Elder

Open access · hybridAbstract readObservational Study
PubMed Full text at PMC Publisher
In one paragraph

Observational study in AIDS research and human retroviruses, 2016. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
0.2field-weighted citation impact, top 38% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed, 4 citations in OpenAlex.

  1. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors at 2 institutions in 1 country.

Elizabeth Fink1 Department of Immunology and Microbial Science, The Scripps Research Institute , La Jolla, California.
Katherine Fuller1 Department of Immunology and Microbial Science, The Scripps Research Institute , La Jolla, California.
Brian Agan2 Infectious Disease Clinical Research Program, Uniformed Services University of the Health Sciences , Bethesda, Maryland.
Edward A Berger4 Laboratory of Viral Diseases, National Institutes of Allergy and Infectious Diseases, The National Institutes of Health , Bethesda, Maryland.
Andrew Saphire1 Department of Immunology and Microbial Science, The Scripps Research Institute , La Jolla, California.
Gerald V Quinnan5 Department of Preventive Medicine and Biostatistics, Uniformed Services University of the Health Sciences , Bethesda, Maryland.
John H Elder1 Department of Immunology and Microbial Science, The Scripps Research Institute , La Jolla, California.
Scripps Research Institute · USUniformed Services University of the Health Sciences · US

Funding

DATA CENTER FOR EPIDEMIOLOGIC INVESTIGATIONS OF HIVN01AI005072 · NIAID · NEW ENGLAND RESEARCH INSTITUTES, INC. · PI MCKINLAY, SONJA M · 1990 to 1994
–
NIAID NIH HHS Y01 AI005072
6 · The paper itself

Abstract

The purpose of this study was to assess humoral antibody responses as a function of disease progression (DP) in a well-defined HIV

Indexed as

Antibody FormationDisease ProgressionAutoantibodiesCD4 AntigensEnzyme-Linked Immunosorbent AssayFemaleHIV AntibodiesHIV InfectionsHuman Immunodeficiency Virus ProteinsHumansMaleProspective StudiesTime FactorsAutoantibodiesCD4 AntigensHIV AntibodiesHuman Immunodeficiency Virus ProteinsADCCenvelopeHIVHIV clinical outcomes research

Identifiers

PMID27771962
PMCPMC5175433
OpenAlexW2557754603

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.